Crescent Capital BDC (NASDAQ:CCAP) Price Target Lowered to $18.00 at Wells Fargo & Company

Crescent Capital BDC (NASDAQ:CCAP) had its price objective decreased by equities research analysts at Wells Fargo & Company from $19.00 to $18.00 in a note issued to investors on Friday,Benzinga reports. The brokerage presently has an “equal weight” rating on the stock. Wells Fargo & Company‘s target price would suggest a potential downside of 5.16% from the stock’s current price.

Separately, Keefe, Bruyette & Woods increased their price objective on Crescent Capital BDC from $19.00 to $20.00 and gave the company an “outperform” rating in a research note on Monday, November 25th. One equities research analyst has rated the stock with a hold rating and five have assigned a buy rating to the company. According to MarketBeat.com, the company currently has an average rating of “Moderate Buy” and an average target price of $19.17.

Crescent Capital BDC Price Performance

Shares of NASDAQ:CCAP opened at $18.98 on Friday. The company has a quick ratio of 1.26, a current ratio of 1.26 and a debt-to-equity ratio of 1.14. The stock has a market cap of $703.44 million, a PE ratio of 9.67 and a beta of 0.81. The company’s fifty day moving average is $19.46 and its 200 day moving average is $18.86. Crescent Capital BDC has a 52 week low of $16.38 and a 52 week high of $20.19.

Crescent Capital BDC (NASDAQ:CCAP) last released its quarterly earnings data on Wednesday, February 19th. The company reported $0.55 EPS for the quarter, missing the consensus estimate of $0.56 by ($0.01). The company had revenue of $46.40 million during the quarter, compared to analysts’ expectations of $47.27 million. Crescent Capital BDC had a return on equity of 11.86% and a net margin of 37.32%. Research analysts anticipate that Crescent Capital BDC will post 2.09 earnings per share for the current year.

Hedge Funds Weigh In On Crescent Capital BDC

A number of hedge funds and other institutional investors have recently made changes to their positions in CCAP. Sun Life Financial Inc. increased its position in Crescent Capital BDC by 20.7% during the 3rd quarter. Sun Life Financial Inc. now owns 2,226,308 shares of the company’s stock valued at $41,187,000 after purchasing an additional 382,542 shares during the period. Kovitz Investment Group Partners LLC bought a new position in Crescent Capital BDC in the third quarter worth about $4,878,000. Raymond James Financial Inc. purchased a new stake in Crescent Capital BDC in the fourth quarter worth about $3,750,000. International Assets Investment Management LLC bought a new stake in Crescent Capital BDC during the 3rd quarter valued at approximately $1,899,000. Finally, Franklin Resources Inc. grew its holdings in shares of Crescent Capital BDC by 35.2% during the 3rd quarter. Franklin Resources Inc. now owns 256,279 shares of the company’s stock worth $4,726,000 after acquiring an additional 66,713 shares during the period. Institutional investors own 49.46% of the company’s stock.

Crescent Capital BDC Company Profile

Crescent Capital BDC, Inc is as a business development company private equity / buyouts and loan fund. It specializes in directly investing. It specializes in middle market. The fund seeks to invest in United States.